RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS

Serial Number 98324339
653

Registration Progress

Application Filed
Dec 20, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS

Basic Information

Serial Number
98324339
Filing Date
December 20, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
653
Status Date
Feb 6, 2025
Application
Pending
Classes
044

Rights Holder

Retinalgenix Technologies Inc.

03
Address
1450 N. McDowell Blvd.
Petaluma, CA 94954

Ownership History

Retinalgenix Technologies Inc.

Original Applicant
03
Petaluma, CA

Legal Representation

Attorney
Megan E. Spitz

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Feb 6, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 6, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 6, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Dec 3, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 2, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 3, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Sep 3, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 31, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 31, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 31, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
High-resolution medical retinal imaging services; Remote monitoring of medical data for medical diagnosis and treatment; DNA and RNA genetic pharmacogenetic mapping for medical diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes

Additional Information

Design Mark
The mark consists of the word RetinalGeniX written in stylized font above the words High-Resolution Retinal Imaging - Home & Remote Monitoring - DNA/RNA GPS Pharmacogenetic Mapping - Diagnostic Testing & Therapeutics Testing Drug Validation & Therapeutics.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
RETINAL GENICS HIGH RESOLUTION RETINAL IMAGING HOME AND REMOTE MONITORING DNA RNA GPS PHARMACOGENETIC MAPPING DIAGNOSTIC TESTING AND THERAPEUTICS TESTING DRUG VALIDATION AND THERAPEUTICS

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS